Abstract
Background—Corticotropin-releasing hormone (CRH) plays a key role in modulating intestinal motility in stressed animals. Aims—To evaluate the effect of CRH on intestinal motility in humans and to determine whether patients with irritable bowel syndrome (IBS) have an exaggerated response to CRH. Subjects—Ten IBS patients diagnosed by Rome criteria and 10 healthy controls. Methods—CRH (2 μg/kg) was intravenously administered during duodenal and colonic manometry and plasma adrenocorticotropic hormone (ACTH) was measured by radioimmunoassay. Results—CRH induced motility of the descending colon in both groups (pConclusion—Human intestinal motility is probably modulated by exogenous CRH. The brain-gut in IBS patients may have an exaggerated response to CRH.